Suppr超能文献

耶和华见证会患者体外膜肺氧合回路的血液节约去除技术:病例报告

Blood-sparing removal technique of extracorporeal membrane oxygenation circuit in a Jehovah Witness patient: Case report.

作者信息

Park Sang Min, Lee Bom, Kim Christopher Y

机构信息

Cardiology Division, Cardiovascular Center, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Republic of Korea.

Utah Cardiology, Farmington, UT.

出版信息

Medicine (Baltimore). 2019 Aug;98(31):e16740. doi: 10.1097/MD.0000000000016740.

Abstract

RATIONALE

Percutaneous cardiopulmonary support (PCPS) using extracorporeal membrane oxygenation (ECMO) is widely used in the critical patients with cardiopulmonary collapse. It is a representative blood-consuming procedure. In limited situations in which the option of blood transfusion is unavailable, there is no general agreement as to whether ECMO is contraindicated.

PATIENT CONCERNS

A 61-year-old male Jehovah Witness with acute respiratory collapse and loss of consciousness was rushed to our emergency room. Throughout his hospital course, the patient's family refused any type of blood transfusion even at the risk of death.

DIAGNOSIS

The clinical situations were secondary to a massive pulmonary thromboembolism INTERVENTIONS:: The patient underwent veno-venous ECMO via both femoral veins. The patient was recovered by intensive medical care although the level of hemoglobin (Hb) and hematocrit (Hct) was gradually decreased from 15.8 g/dl and 46.8% to 11.7 g/dl and 36.5%, respectively.

OUTCOMES

On hospital day 3, ECMO was successfully removed using a blood-sparing ECMO removal technique involving the recycling of blood within the circuit by continuous saline infusion. There was no significant change in level of Hb/Hct and hemodynamic profile. At 2 days after ECMO removal, the level of Hb/Hct was elevated up to 9.2 g/dl and 30.0%, respectively without any transfusion.

LESSONS

Our blood-sparing removal technique of ECMO appears to be feasible and led to no significant adverse impact on hemodynamic status. The technique might be helpful for critical patients who cannot receive blood transfusion due to any cause.

摘要

理论依据

使用体外膜肺氧合(ECMO)的经皮心肺支持(PCPS)广泛应用于心肺功能衰竭的危重症患者。这是一种典型的消耗血液的操作。在无法选择输血的有限情况下,对于ECMO是否为禁忌尚无普遍共识。

患者情况

一名61岁的男性耶和华见证会信徒因急性呼吸衰竭和意识丧失被紧急送往我们的急诊室。在整个住院过程中,患者家属拒绝任何形式的输血,即使面临死亡风险。

诊断

临床情况继发于大面积肺血栓栓塞。

干预措施

患者通过双侧股静脉接受静脉-静脉ECMO治疗。尽管血红蛋白(Hb)水平和血细胞比容(Hct)分别从15.8g/dl和46.8%逐渐降至11.7g/dl和36.5%,但患者通过强化医疗护理得以康复。

结果

在住院第3天,使用一种节省血液的ECMO撤机技术成功撤机,该技术通过持续输注生理盐水使回路内的血液再循环。Hb/Hct水平和血流动力学参数无显著变化。在ECMO撤机后2天,Hb/Hct水平分别升至9.2g/dl和30.0%,未进行任何输血。

经验教训

我们的ECMO节省血液撤机技术似乎可行,且对血流动力学状态无显著不良影响。该技术可能有助于因任何原因无法接受输血的危重症患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/6709167/d96dc2c5796a/medi-98-e16740-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验